The history of anti-obesity pharmacotherapies is marked by disappointments, often
entangled with societal pressure promoting weight loss and the prevailing conviction that …

The natural history of metabolic dysfunction-associated steatotic liver disease (MASLD),
previously referred to as non-alcoholic fatty liver disease (NAFLD), is complex and long. A …

Chronic stress has been shown to induce hyperglycemia in both peripheral blood and the
brain, yet the detailed mechanisms of glucose metabolism under stress remain unclear …

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a growing global health
problem, affecting∼ 1 billion people. This condition is well established to have a heritable …

Abstract Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD) is recognized
as a metabolic disease characterized by excess intrahepatic lipid accumulation due to lipid …

Chronic liver diseases (CLD) stem from various causes and lead to a gradual progression
that ultimately may result in fibrosis and eventually cirrhosis. This process is typically …

Patients suffering from an inherited severe liver disorder require lifelong treatment to prevent
premature death. Until recently, the only curative treatment option was liver transplantation …

Aim The aim was to examine the prevalence of metabolic dysfunction–associated steatotic
liver disease (MASLD), a risk factor for atherosclerotic cardiovascular disease, and its …

The pathogenesis of liver diseases is multifaceted and intricate, posing a persistent global
public health challenge with limited therapeutic options. Therefore, further research into liver …

As the number of cancer survivors increases and the risk of accidental radiation exposure
rises, there is a pressing need to characterize the delayed effects of radiation exposure and …